Skip to main content

Table 3 Distribution of chronic comorbidities in chronic patients > 65 years of age during the year of study, overall and by sex and age groups

From: Chronic diseases in the geriatric population: morbidity and use of primary care services according to risk level

Chronic comorbidity
n (%)
Total
3292 (100)
Men
1125 (34.2)
Women
2167 (65.8)
p 66–75 years
1409 (42.8)
76–85 years
1239 (37.6)
>  85 years
644 (19.6)
p
Anaemia 268 (8.1) 87 (7.7) 181 (8.4) 0.5 60 (4.3) 112 (9.0) 96 (14.9) < 0.01
Human immunodeficiency virus (HIV) 4 (0.1) 4 (0.4) 0 (0.0) < 0.01 4 (0.3) 0 (0.0) 0 (0.0) 0.07
Cirrhosis 210 (6.4) 73 (6.5) 137 (6.3) 0.8 111 (7.9) 72 (5.8) 27 (4.2) < 0.01
Gastrointestinal ulcer 90 (2.7) 46 (4.1) 44 (2) < 0.01 33 (2.3) 44 (3.6) 13 (2) 0.08
Inflammatory bowel disease 25 (7.6) 12 (1.1) 13 (0.3) 0.1 14 (1.0) 8 (0.6) 3 (0.5) 0.4
Aortic aneurysm 39 (1.2) 33 (2.9) 6 (0.3) < 0.01 6 (0.4) 23 (1.9) 10 (1.6) < 0.01
Ischaemic heart disease 285 (8.7) 171 (15.2) 114 (5.3) < 0.01 83 (5.9) 126 (10.2) 76 (11.8) < 0.01
Dysrhythmias 512 (15.6) 204 (18.1) 308 (14.2) < 0.01 108 (7.7) 233 (18.8) 171 (26.6) < 0.01
Hypertension 2224 (67.6) 789 (70.1) 1435 (66.2) 0.02 801 (56.8) 910 (73.4) 513 (79.7) < 0.01
Stroke 204 (6.2) 88 (7.8) 116 (5.4) < 0.01 44 (3.1) 95 (7.7) 65 (10.1) < 0.01
Heart chronic failure 217 (6.6) 73 (6.5) 144 (6.6) 0.9 34 (2.4) 87 (7.0) 96 (14.9) < 0.01
Valvular heart disease 144 (4.4) 52 (4.6) 92 (4.2) 0.6 47 (3.3) 52 (4.2) 45 (7.0) < 0.01
Obstructive chronic pulmonary disease 268 (8.1) 148 (13.2) 120 (5.5) < 0.01 95 (6.7) 119 (9.6) 54 (8.4) 0.03
Asthma 172 (5.2) 30 (2.7) 142 (6.6) < 0.01 78 (5.5) 68 (5.5) 26 (4) 0.3
Arthritis 96 (2.8) 24 (2.1) 72 (3.3) 0.05 38 (2.7) 37 (3.0) 21 (3.3) 0.8
Osteoarthritis 707 (21.5) 157 (14.0) 550 (25.4) < 0.01 284 (20.2) 294 (23.7) 129 (20.0) 0.05
Osteoporosis 806 (24.5) 28 (2.5) 778 (35.9) < 0.01 361 (25.6) 308 (24.9) 137 (21.3) 0.1
Dementia 203 (6.2) 45 (4.0) 158 (7.3) < 0.01 14 (1.0) 78 (6.3) 111 (17.2) < 0.01
Epilepsy 57 (1.7) 18 (1.6) 39 (1.8) 0.7 15 (1.1) 28 (2.3) 14 (2.2) 0.04
Parkinson 75 (2.3) 34 (3.0) 41 (1.9) 0.04 21 (1.5) 38 (3.1) 16 (2.5) 0.02
Alcohol abuse 106 (3.2) 77 (6.8) 29 (1.3) < 0.01 57 (4.0) 33 (2.7) 16 (2.5) 0.07
Substance abuse 5 (0.1) 2 (0.2) 3 (0.1) 0.8 2 (0.1) 3 (0.2) 0 (0.0) 0.4
Anxiety 607 (18.4) 128 (11.4) 479 (22.1) < 0.01 296 (21.0) 217 (17.5) 94 (14.6) < 0.01
Depression 525 (15.9) 104 (9.2) 421 (19.4) < 0.01 206 (14.6) 201 (16.2) 118 (18.3) 0.1
Diabetes Mellitus 708 (21.5) 322 (28.6) 386 (17.8) < 0.01 280 (19.9) 293 (23.6) 135 (21.0) 0.06
Dyslipidaemia 1937 (58.8) 652 (58.0) 1285 (59.3) < 0.01 822 (58.3) 788 (63.6) 327 (50.8) < 0.01
Obesity 683 (20.7) 224 (19.9) 459 (21.2) 0.4 294 (20.9) 287 (23.2) 102 (15.8) < 0.01
Thyroid disorder 659 (20.0) 109 (9.7) 550 (25.4) < 0.01 298 (21.1) 251 (20.3) 110 (17.1) 0.1
Renal chronic failure 128 (3.9) 60 (5.3) 68 (3.1) < 0.01 15 (1.1) 62 (5.0) 51 (7.9) < 0.01
Glaucoma 285 (8.7) 86 (7.6) 199 (9.2) 0.1 93 (6.6) 116 (9.4) 76 (11.8) < 0.01
Active neoplasia 295 (8.9) 159 (14.1) 136 (6.3) < 0.01 102 (7.2) 132 (10.7) 61 (9.5) < 0.01
 Breast neoplasia 37 (1.1) 1 (0.1) 36 (1.7) < 0.01 12 (0.9) 17 (1.4) 8 (1.2) 0.4
  Prostate neoplasia 55 (1.7) 55 (4.9) 0 (0.0) < 0.01 20 (1.4) 23 (1.9) 12 (1.9) 0.6
  Colorectal neoplasia 38 (1.2) 19 (1.7) 19 (0.9) 0.04 15 (1.1) 16 (1.3) 7 (1.1) 0.8
  Skin neoplasia 37 (1.1) 13 (1.2) 24 (1.1) 0.9 10 (0.7) 20 (1.6) 7 (1.1) 0.9
  Lung neoplasia 24 (0.7) 13 (1.2) 11 (0.5) 0.04 11 (0.8) 6 (0.5) 7 (1.1) 0.3
  Lymphoma 32 (0.9) 10 (0.9) 22 (1.0) 0.7 10 (0.7) 19 (1.5) 3 (0.5) 0.03
  Bladder neoplasia 23 (0.7) 21 (1.9) 2 (0.1) < 0.01 9 (0.6) 8 (0.6) 6 (0.9) 0.7
  Leukaemia 19 (0.5) 11 (1.0) 8 (0.4) 0.03 5 (0.4) 10 (0.8) 4 (0.6) 0.3